Matrix metalloproteinases genes polymorphism in the development of new cardiovascular events

Journal of Clinical Medicine of Kazakhstan, 2020

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.23950/1812-2892-jcmk-00778
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The review article presents a study of the literature on the relationship of gene polymorphism of matrix metalloproteinases (MMP 2 (−1575 G>A), MMP3 (−1171 5A/6A), MMP 9 (−1562 C/T) with the risk of developing new cardiovascular events after percutaneous coronary intervention. To achieve this goal, a systematic search and subsequent analysis of publications and online resources was carried out. All publications are indexed in Scopus, Web of Knowledge and e-library.